Skip to main content
. 2017 Mar 24;18:53. doi: 10.1186/s13059-017-1191-5

Fig. 4.

Fig. 4

Classification performances of three methods (CancerLocator, RF and SVM) on the ten subsets of simulation data. Each subset includes plasma cfDNA samples at certain cancer stage (represented as a ctDNA burden range)